The European high-flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018. The market is projected to grow with a CAGR of 10.8% from 2019-2027. The growth of the market is majorly contributed by the increased lung cancer conferences across Europe, and growing asthma cases in adults in children are expected to boost the market growth over the years. However, side effects associated with high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years. Asthma is the lifelong chronic inflammatory disorder of the airways that affects adults and children of all ages.According to the European Respiratory Society, Asthma is a chronic inflammatory disease of the airways that causes recurring episodes of wheezing, breathlessness, chest tightness, and coughing.
It is the most common disease that affects people of all ages in all countries in Europe.As per data published, about 30 million adults less than 45 old, and children have asthma in their lifetime.
The incidence of asthma has been increased substantially in Europe, at some time between 1950 and 2000. As per the data obtained from the European Community Respiratory Health Survey and local health institutions, the prevalence in adults is highest in the UK (10% - 13%). In 2018, the UK high-flow nasal cannula market held the largest share of the Europe high-flow nasal cannula market.The hospital segment expected to dominate the Europe high-flow nasal cannula market.
Additionally, this segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Similarly, in 2018 the active humidifier segment held the major market share among the component segments. In 2018, the active humidifier segment held a largest market share of the high-flow nasal cannula market, by Component.The active humidifier is expected to dominate its market share in 2027 because it provides moisture and heat to respiratory gas through an electrically powered humidifier.
The active humidifier segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018. However, bronchiectasis segment expected to have largest market in 2027 because diagnosis of bronchiectasis has been growing consistently since 2001 and its prevalence is more in elder population. Hospital segment held the largest market share of the high-flow nasal cannula market, by end user, owing to its benefits offered, such as proper patient-centric care, availability of reimbursement facilities. Some of the major primary and secondary sources for drug delivery systems included in the report are Chest Research Foundation, The European Environment Agency, the German Centre for Addiction Issues, etc.
Our reports have been used by over 10K customers, including:
236 pages •
By The Business Research Company
• Feb 2022
Nebulizers Global Market Opportunities And Strategies To 2030: COVID 19 Implications And Growth provides the strategists; marketers and senior management with the critical information they need to assess the global nebulizers market as it emerges from the COVID 19 shut down. Description: Where is the largest and...
The respiratory care devices market is expected to reach USD 27.6 billion by 2026 from USD 18.4 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. The major factor driving the growth of the respiratory...
The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral...
Scope of the Report The report titled “Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in-depth analysis of the global respiratory care medical devices market with description of market sizing and growth. The analysis includes market by value and market share by...
The respiratory ventilator tester market was valued at US$ 148.00 million in 2019 and is projected to reach US$ 199.20 million by 2027; it is expected to grow at a CAGR of 3.8% from 2020 to 2027. The growth of the market is mainly attributed to factors such as growing prevalence of respiratory diseases and increasing geriatric population....
The global respiratory care devices market is expected to reach nearly US$ 35 Billion by 2026. Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. Respiratory care devices are used for the diagnosis, treatment, and monitoring of patients who are suffering from...
The Europe pulmonary devices market is expected to reach US$ 11,398.02 million by 2027 from US$ 5,459.48 million in 2019. The market is estimated to grow at a CAGR of 9.7% during 2019–2027. The growth of the pulmonary devices market in Europe is attributed to the increasing prevalence of respiratory diseases and growing number of COVID-19...
The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is estimated to grow at a CAGR of 10.3% during 2019–2027. The growth of the pulmonary devices market in North America is attributed to the increasing prevalence of respiratory diseases and growing...
The Asia Pacific pulmonary devices market is expected to reach US$ 8,196.82 million by 2027 from US$ 3,661.53 million in 2019. The market is estimated to grow at a CAGR of 10.6 % during 2019–2027. The growth of the pulmonary devices market in Asia Pacific is attributed to the increasing prevalence of respiratory diseases and growing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Respiratory Inhalers Market Report The respiratory inhalers market by revenue is expected to grow at a CAGR of over 9% during the period 2019–2025. The global respiratory inhalers market is one of the steadily growing segments in...
Respiratory Device
World
Asthma Prevalence
Chronic Obstructive Pulmonary Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.